CORD-19:ba334a8f734285257878e0df4e64a6131818d0c6 / 60468-60824 JSONTXT

{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T52","span":{"begin":0,"end":356},"obj":"Sentence"}],"text":"The development of RNA polymerase inhibitors involves either the (structure-based) design of nucleoside analogues that are recognized by the polymerase and incorporated into the viral RNA genome or the screening for or designing of small molecules that inhibit nucleotide synthesis by binding to the RNA polymerase and prevent it from functioning properly."}

{"project":"CORD-19-Sentences","denotations":[{"id":"TextSentencer_T293","span":{"begin":0,"end":356},"obj":"Sentence"},{"id":"T45356","span":{"begin":0,"end":356},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"The development of RNA polymerase inhibitors involves either the (structure-based) design of nucleoside analogues that are recognized by the polymerase and incorporated into the viral RNA genome or the screening for or designing of small molecules that inhibit nucleotide synthesis by binding to the RNA polymerase and prevent it from functioning properly."}